Astellas Pharma
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Astellas Pharma's balance sheet done over the years? Its assets were worth $3,569,603,000,000 last year, which is more than in the previous period. 55% of Astellas Pharma’s total assets is currently financed by debt. Its liabilities reached the amount of $1,973,615,000,000, which means an increase by 108% compared compared to last year.
Debt to Assets
| 2015 | 1793578000000 | 475.66B | 26.52% |
|---|---|---|---|
| 2016 | 1799338000000 | 540.12B | 30.02% |
| 2017 | 1814072000000 | 542.26B | 29.89% |
| 2018 | 1858205000000 | 589.91B | 31.75% |
| 2019 | 1897648000000 | 639.25B | 33.69% |
| 2020 | 2315169000000 | 1.02T | 44.32% |
| 2021 | 2273628000000 | 887.51B | 39.04% |
| 2022 | 2332395000000 | 872.08B | 37.39% |
| 2023 | 2456518000000 | 948.56B | 38.61% |
| 2024 | 3569603000000 | 1.97T | 55.29% |
ALPMY Balance Sheet (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 335.68B | 376.84B | 315.98B | 326.12B | 318.39B | 311.07B | 331.73B | 340.92B | 360.03B | 396.43B |
Short term investments | 28.78B | 19.78B | 21.29B | 5.56B | 9.45B | 2.60B | 13.51B | 13.55B | 290M | 59.90B |
Net receivables | 534.98B | 427.96B | 404.00B | 357.16B | 370.59B | 362.74B | 327.92B | 309.81B | 358.10B | 332.92B |
Inventory | 248.73B | 174.38B | 153.07B | 164.08B | 151.01B | 151.51B | 147.62B | 182.53B | 161.69B | 156.90B |
Other current assets | 46.53B | 70.76B | 50.29B | 25.21B | 27.50B | 31.83B | 38.33B | 43.38B | 17.42B | 19.79B |
Total current assets | 1.19T | 1.04T | 923.35B | 872.58B | 867.51B | 857.15B | 845.61B | 876.66B | 897.53B | 965.95B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 293.74B | 286.45B | 269.04B | 264.62B | 268.6B | 173.48B | 181.29B | 191.11B | 200.95B | 202.86B |
Goodwill | 418.69B | 328.41B | 303.03B | 284.01B | 278.25B | 225.86B | 212.97B | 168.52B | 150.66B | 136.33B |
Intangible assets | 1.45T | 562.49B | 623.43B | 651.42B | 724.77B | 429.70B | 416.91B | 387.41B | 339.20B | 295.84B |
Long term investments | 144.42B | 134.74B | 131.67B | 136.89B | 112.97B | 110.35B | 85.06B | 76.44B | 115.96B | 141.37B |
Other non-current assets | 45.59B | 10.28B | 9.53B | 9.91B | 10.18B | 8.11B | 19.10B | 16.73B | 14.77B | 51.19B |
Total non-current assets | 2.37T | 1.40T | 1.40T | 1.40T | 1.44T | 1.04T | 1.01T | 937.40B | 901.80B | 827.62B |
Total assets | 3.56T | 2.45T | 2.33T | 2.27T | 2.31T | 1.89T | 1.85T | 1.81T | 1.79T | 1.79T |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 5.13B | 32.38B | 8.39B | 11.69B | 13.32B | 60.02B | 58.9B | 28.77B | 0 |
Short term debt | 472.27B | 75B | 157.73B | 136.10B | 344.10B | 430M | 444M | 0 | 505M | 0 |
Total current liabilities | 1.28T | 726.03B | 687.41B | 592.37B | 798.70B | 497.66B | 421.62B | 399.85B | 413.35B | 420.89B |
| Non-current liabilities: | ||||||||||
Long term debt | 447.73B | 50B | 676M | 80B | 3.14B | 1.57B | 3.51B | 1.57B | 1.59B | 716M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 240.15B | 111.06B | 123.83B | 134.81B | 198.83B | 123.43B | 116.05B | 88.16B | 63.48B | 54.05B |
Total non-current liabilities | 687.89B | 222.53B | 184.67B | 295.14B | 227.29B | 141.58B | 168.29B | 142.40B | 126.77B | 54.77B |
Total liabilities | 1.97T | 948.56B | 872.08B | 887.51B | 1.02T | 639.25B | 589.91B | 542.26B | 540.12B | 475.66B |